EC Client Consultation and Skin Analysis 2 — Questions and Answers
Question 1: A client reports taking isotretinoin (Accutane) six months ago. What is the correct course of action?
- Proceed with treatment since it has been six months
- Require the client to wait a full 12 months after stopping the medication before treatment (Correct answer)
- Treat only the legs and avoid the face
- Request a physician's written clearance and treat with lower intensity
Correct answer: Require the client to wait a full 12 months after stopping the medication before treatment
Most professional guidelines recommend waiting at least 12 months after stopping isotretinoin before performing electrolysis due to skin sensitivity and impaired healing.
Question 2: During skin analysis, you notice telangiectasia (spider veins) in the treatment area. How does this affect your electrolysis approach?
- Telangiectasia is a contraindication; cancel the treatment entirely
- Avoid inserting the probe directly into or over visible broken capillaries to prevent further damage (Correct answer)
- Increase current intensity to cauterize the vessels during treatment
- No modification is needed; proceed normally
Correct answer: Avoid inserting the probe directly into or over visible broken capillaries to prevent further damage
Working directly over telangiectasia can further damage fragile capillaries, so practitioners should avoid those areas or use extra caution.
Question 3: A client discloses they have a history of post-inflammatory hyperpigmentation (PIH). Which skin phototype are they most likely to have?
- Fitzpatrick Type I or II
- Fitzpatrick Type III or IV
- Fitzpatrick Type IV, V, or VI (Correct answer)
- PIH is unrelated to Fitzpatrick skin type
Correct answer: Fitzpatrick Type IV, V, or VI
Post-inflammatory hyperpigmentation is most prevalent and persistent in Fitzpatrick skin types IV–VI due to higher melanin activity.
Question 4: What is the PRIMARY purpose of performing a patch test before a full electrolysis session?
- To determine the client's pain threshold
- To assess the client's skin reaction to current intensity and probe insertion (Correct answer)
- To map out all the hair follicles in the treatment area
- To satisfy legal liability requirements only
Correct answer: To assess the client's skin reaction to current intensity and probe insertion
A patch test evaluates how the client's skin responds to the modality, current level, and technique before committing to a full treatment.
Question 5: A client's intake form shows they are on long-term corticosteroid therapy. What skin characteristic should you anticipate?
- Thickened, hyperkeratotic skin
- Thinned, fragile skin with reduced healing capacity (Correct answer)
- Oily skin with enlarged pores
- Increased skin elasticity
Correct answer: Thinned, fragile skin with reduced healing capacity
Long-term corticosteroid use causes skin atrophy, thinning, and impaired wound healing, requiring gentler treatment parameters.
Question 6: During consultation, a client mentions they frequently use exfoliating acids (AHAs/BHAs). What pre-treatment instruction is appropriate?
- Instruct the client to increase acid use to improve follicle access
- Ask the client to discontinue exfoliating acids at least 48–72 hours before treatment (Correct answer)
- No special instructions are needed for topical acid users
- Recommend the client apply acids immediately before the appointment
Correct answer: Ask the client to discontinue exfoliating acids at least 48–72 hours before treatment
Exfoliating acids thin and sensitize the skin barrier, increasing the risk of adverse reactions during electrolysis if used too close to the appointment.
Question 7: When documenting a client's medical history, which condition would require the electrologist to obtain written physician clearance before proceeding?
- Mild seasonal allergies
- Controlled type 2 diabetes
- A recent organ transplant with immunosuppressant therapy (Correct answer)
- Mild eczema on a non-treatment area
Correct answer: A recent organ transplant with immunosuppressant therapy
Immunosuppressant therapy significantly impairs healing and infection resistance, making physician clearance essential before invasive procedures.
A client reports taking isotretinoin (Accutane) six months ago.
What is the correct course of action?